Thu, November 10, 2022
Wed, November 9, 2022
Tue, November 8, 2022
Mon, November 7, 2022

Steven Seedhouse Maintained (ANAB) at Buy with Increased Target to $38 on, Nov 9th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-38-on-nov-9th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Steven Seedhouse of Raymond James, Maintained "AnaptysBio, Inc." (ANAB) at Buy with Increased Target from $30 to $38 on, Nov 9th, 2022.

Steven has made no other calls on ANAB in the last 4 months.



There are 3 other peers that have a rating on ANAB. Out of the 3 peers that are also analyzing ANAB, 1 agrees with Steven's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • John Lee of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $28 on, Tuesday, September 13th, 2022


These are the ratings of the 2 analyists that currently disagree with Steven


  • Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy on, Tuesday, November 1st, 2022
  • Gobind Singh of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $35 on, Monday, September 19th, 2022

Publication Contributing Sources